We believe that in-depth study of the downstream molecular mechanisms related to PLCG2 will be a direction for future research, which will provide a new perspective for further understanding of the pathogenesis of STS and the selection of diagnostic and therapeutic targets. This evidence concerns the gene PLCG2 and telomere syndrome.